del Nido versus hematic cardioplegia in minimally invasive aortic valve surgery
Asian Cardiovascular and Thoracic Annals · 2023
DOI: 10.1177/02184923231209858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Cardiovascular and Thoracic Annals, 2023. Verfasst von Alberto Pozzoli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Heart Surgery Unit, Cardiocentro Ticino Institute, EOC, Lugano, Switzerland. Hauptthemen laut MEDLINE: Aortic Valve, Cardioplegic Solutions. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
The quality of a myocardial protection of a single-dose del Nido cardioplegia versus multiple dose blood-based cardioplegia on myocardial injury, outcomes and operative times in patients undergoing minimally invasive aortic valve replacement is basically unreported. Methods and Results Preoperative and post-operative data, as well as technical details from isolated minimally invasive aortic valve replacements, performed using single-dose or multiple-dose cardioplegia were prospectively collected and retrospectively analysed. A total of 110 patients undergoing minimally invasive valve replacements at our institution composed two groups: 55 patients in the blood cardioplegia group (BloCa) and 55 in the del Nido group (DeNiCa). The two-matched groups were comparable in terms of preoperative variables. In the DeNiCa group, there was a statistically significant less need for cardiac defibrillation after aortic cross-clamp release ( p < 0.001). Moreover, the BloCa group received intraoperatively more blood transfusions ( p = 0.001) and more insulin administration for higher glucose levels ( p < 0.001). The BloCa group showed higher intraoperative lactate levels ( p = 0.01). Need for post-operative inotropic and vasoactive support, Creatine Kinase-MB levels after 6 and 12 h, onset of post-operative atrial fibrillation and length of stay were similar. No deaths occurred in neither groups.
Conclusion
Single-dose del Nido cardioplegia in the setting of minimally invasive aortic surgery seems to offer adequate myocardial protection, comparable to multiple dose hematic cardioplegia. It has been documented a lower peri-operative need of defibrillation after cross-clamp release, lactate- and glucose peak values, as well as less blood transfusions compared to blood cardioplegic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Surgery Unit, Cardiocentro Ticino Institute, EOC, Lugano, Switzerland.
- Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Alberto Pozzoli, Francesca Toto
Zitieren
APA
Pozzoli, A., Gabriella Surace, G., Torre, T., Bagnato, P., Gallo, M., Toto, F., Ferrari, E., & Demertzis, S. (2023). del Nido versus hematic cardioplegia in minimally invasive aortic valve surgery. Asian Cardiovascular and Thoracic Annals. https://doi.org/10.1177/02184923231209858
Vancouver
Pozzoli A, Gabriella Surace G, Torre T, Bagnato P, Gallo M, Toto F, et al. del Nido versus hematic cardioplegia in minimally invasive aortic valve surgery. Asian Cardiovascular and Thoracic Annals. 2023. doi:10.1177/02184923231209858
BibTeX
@article{Pozzoli2023,
author = {Pozzoli, Alberto and Gabriella Surace, Giuseppina and Torre, Tiziano and Bagnato, Pietro and Gallo, Michele and Toto, Francesca and Ferrari, Enrico and Demertzis, Stefanos},
title = {del Nido versus hematic cardioplegia in minimally invasive aortic valve surgery},
journal = {Asian Cardiovascular and Thoracic Annals},
year = {2023},
doi = {10.1177/02184923231209858}
}
EUVIMED